U.S. markets closed
  • S&P 500

    3,585.15
    +48.14 (+1.36%)
     
  • Dow 30

    29,479.81
    +399.64 (+1.37%)
     
  • Nasdaq

    11,829.29
    +119.70 (+1.02%)
     
  • Russell 2000

    1,744.04
    +35.57 (+2.08%)
     
  • Crude Oil

    40.12
    -1.00 (-2.43%)
     
  • Gold

    1,888.20
    +14.90 (+0.80%)
     
  • Silver

    24.76
    +0.45 (+1.87%)
     
  • EUR/USD

    1.1837
    +0.0027 (+0.22%)
     
  • 10-Yr Bond

    0.8930
    +0.0080 (+0.90%)
     
  • GBP/USD

    1.3201
    +0.0083 (+0.64%)
     
  • USD/JPY

    104.6200
    -0.4790 (-0.46%)
     
  • BTC-USD

    15,971.99
    -1.65 (-0.01%)
     
  • CMC Crypto 200

    315.08
    +2.21 (+0.71%)
     
  • FTSE 100

    6,316.39
    -22.55 (-0.36%)
     
  • Nikkei 225

    25,385.87
    -135.01 (-0.53%)
     

Mike Khouw Sees Unusually High Options Activity In Moderna

Craig Jones
·1 min read

On CNBC's "Options Action," Mike Khouw said Moderna Inc (NASDAQ: MRNA) saw more than 3 times the average daily options volume on Friday, and calls significantly outpaced puts.

The most active options were the $90-strike calls, $100-strike calls and $105-strike calls that expire on November 20. This activity suggests traders are expecting a strong vaccine-related catalyst next week and they are using options because they want to manage risk, explained Khouw.

Tony Zhang made a comparison with Pfizer Inc. (NYSE: PFE), which had a big move higher on the news and then it traded lower. He expects to see a similar reaction with Moderna. He wouldn't chase it because its options are very expensive.

Carter Worth likes Moderna a lot. He expects it to trade above its highs.

 

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.